CINECA IRIS Institutional Research Information System

VEGLIO, Franco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.465
AS - Asia 14.914
EU - Europa 12.464
SA - Sud America 2.339
OC - Oceania 506
AF - Africa 343
Continente sconosciuto - Info sul continente non disponibili 14
AN - Antartide 1
Totale 50.046
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.676
CN - Cina 5.205
SG - Singapore 4.275
IT - Italia 2.696
BR - Brasile 1.581
DE - Germania 1.573
VN - Vietnam 1.386
FR - Francia 1.316
IE - Irlanda 1.170
FI - Finlandia 959
JP - Giappone 863
SE - Svezia 766
GB - Regno Unito 753
UA - Ucraina 745
KR - Corea 722
HK - Hong Kong 482
AU - Australia 474
CA - Canada 465
IN - India 417
PL - Polonia 403
AT - Austria 330
ES - Italia 316
AR - Argentina 284
NL - Olanda 243
TW - Taiwan 241
MX - Messico 235
TR - Turchia 228
ID - Indonesia 185
RU - Federazione Russa 173
BD - Bangladesh 159
GR - Grecia 148
CO - Colombia 142
CH - Svizzera 133
BE - Belgio 132
IQ - Iraq 104
DK - Danimarca 103
TH - Thailandia 96
CL - Cile 95
PT - Portogallo 88
ZA - Sudafrica 76
EC - Ecuador 72
RO - Romania 61
SA - Arabia Saudita 61
MY - Malesia 57
PK - Pakistan 56
IL - Israele 52
CZ - Repubblica Ceca 48
PE - Perù 48
PH - Filippine 48
MA - Marocco 46
UZ - Uzbekistan 43
VE - Venezuela 43
PY - Paraguay 39
EG - Egitto 37
LT - Lituania 36
KE - Kenya 31
NZ - Nuova Zelanda 31
BG - Bulgaria 30
DZ - Algeria 30
JO - Giordania 28
NO - Norvegia 28
TN - Tunisia 27
AE - Emirati Arabi Uniti 26
NG - Nigeria 23
HR - Croazia 22
NP - Nepal 21
BA - Bosnia-Erzegovina 20
IS - Islanda 20
JM - Giamaica 19
HU - Ungheria 18
IR - Iran 18
LU - Lussemburgo 17
RS - Serbia 17
UY - Uruguay 17
BO - Bolivia 16
SI - Slovenia 16
AL - Albania 15
SK - Slovacchia (Repubblica Slovacca) 15
AZ - Azerbaigian 14
GE - Georgia 13
OM - Oman 13
BY - Bielorussia 12
LB - Libano 12
QA - Qatar 12
CR - Costa Rica 11
MU - Mauritius 11
ET - Etiopia 10
SN - Senegal 10
DO - Repubblica Dominicana 9
LV - Lettonia 9
MT - Malta 9
PS - Palestinian Territory 9
EE - Estonia 8
EU - Europa 8
GT - Guatemala 8
KG - Kirghizistan 8
KW - Kuwait 8
MD - Moldavia 8
PA - Panama 8
TT - Trinidad e Tobago 8
Totale 49.908
Salva come PNG Salva come JPEG
Città #
Singapore 2.421
Beijing 2.148
Chandler 1.468
Ashburn 1.348
Houston 1.266
Dublin 1.137
San Jose 1.058
Santa Clara 987
Ann Arbor 763
Fairfield 598
Torino 518
Jacksonville 447
Villeurbanne 431
Redwood City 422
Helsinki 371
Wilmington 369
Ho Chi Minh City 366
Medford 357
The Dalles 346
Los Angeles 342
Princeton 338
Lauterbourg 337
Warsaw 321
Columbus 316
Hong Kong 316
Turin 311
Woodbridge 281
Milan 272
Tokyo 271
New York 268
Seoul 265
Hanoi 258
Melbourne 252
Vienna 252
Seattle 246
Nyköping 234
Munich 221
Buffalo 219
Dallas 211
Hefei 210
Dong Ket 200
Shanghai 199
São Paulo 188
Cambridge 178
Düsseldorf 178
Boston 177
Dearborn 168
Guangzhou 163
Taipei 146
Fremont 145
Pisa 141
Hangzhou 118
Council Bluffs 115
Boardman 114
Nanjing 107
Nuremberg 105
Jakarta 103
Chengdu 102
Chongqing 102
Verona 102
Frankfurt am Main 92
Rome 90
London 84
Buenos Aires 83
Chicago 82
Paris 82
Toronto 77
Brussels 71
Istanbul 69
Norwalk 67
Bengaluru 66
Ottawa 66
Montreal 62
Rio de Janeiro 62
Phoenix 61
Santiago 61
Madrid 60
Orem 60
Amsterdam 55
Shenzhen 54
Zhengzhou 54
Athens 53
Changsha 53
Redondo Beach 53
Washington 53
Wuhan 52
San Diego 51
Bangkok 50
Falls Church 50
Sydney 50
Da Nang 49
Detroit 49
Padova 49
Stockholm 49
Turku 49
Manchester 47
Moscow 47
Haiphong 46
Barcelona 45
Lachine 44
Totale 27.810
Salva come PNG Salva come JPEG
Nome #
Renal damage in primary aldosteronism: a systematic review and meta-analysis 1.614
Prevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice 1.044
Adrenal vein sampling in primary aldosteronism: towards a standardised protocol. 956
Diagnostic accuracy of aldosterone and renin measurement by chemiluminescent immunoassay and radioimmunoassay in pr imar y aldosteronism 881
Guidelines for primary aldosteronism: uptake by primary care physicians in Europe 811
Echocardiographic aortic root dilatation in hypertensive patients: a systematic review and meta-analysis. 706
Long-Term Cardio- and Cerebrovascular Events in Patients With Primary Aldosteronism 664
The spectrum of low-renin hypertension 653
Neurologic and cognitive outcomes after aortic arch operation with hypothermic circulatory arrest 611
Development and validation of prediction models for subtype diagnosis of patients with primary aldosteronism 555
Prediction of hyperaldosteronism subtypes when adrenal vein sampling is unilaterally successful 547
Liver X receptor activation reduces angiogenesis by impairing lipid raft localization and signaling of vascular endothelial growth factor receptor-2 517
Clinically guided genetic screening in a large cohort of italian patients with pheochromocytomas and/or functional or nonfunctional paragangliomas 486
Hyperaldosteronism: How to Discriminate Among Different Disease Forms? 444
The expanding genetic horizon of primary aldosteronism 443
Approach to the Patient on Antihypertensive Therapy: Screen for Primary Aldosteronism 429
Somatic ATP1A1, ATP2B3, and KCNJ5 Mutations in Aldosterone-Producing Adenomas 415
Primary Aldosteronism and Obstructive Sleep Apnea: A Cross-Sectional Multi-Ethnic Study 406
Central pressure appraisal: Clinical validation of a subject-specific mathematical model 402
Cardiorenal end points in a trial of aliskiren for type 2 diabetes 394
Quality of life in primary aldosteronism: A prospective observational study 377
Ascending aortic dilatation, arterial stiffness and cardiac organ damage in essential hypertension 376
Aldosterone suppression on contralateral adrenal during adrenal vein sampling does not predict blood pressure response after adrenalectomy. 368
Primary Aldosteronism and Obstructive Sleep Apnea: Casual Association or Pathophysiological Link? 360
Coexisting prolactinoma and primary aldosteronism: Is there a pathophysiological link? 355
Subtype Diagnosis of Primary Aldosteronism: Approach to Different Clinical Scenarios 341
Comparison of Automated Office Blood Pressure With Office and Out-Off-Office Measurement Techniques 325
Aldosterone effects on glomerular structure and function 318
THE STORM (acute coronary Syndrome in paTients end Of life and Risk assesMent) study Claudio Moretti 316
Prevalence of Hypokalemia and Primary Aldosteronism in 5100 Patients Referred to a Tertiary Hypertension Unit 292
Aortic root dilatation in essential hypertension: prevalence according to new reference values 281
Is there a role for genomics in the management of hypertension? 281
Development of a Prediction Score to Avoid Confirmatory Testing in Patients With Suspected Primary Aldosteronism 281
Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients with Primary Aldosteronism 276
Subtype Diagnosis of Primary Aldosteronism: Is Adrenal Vein Sampling Always Necessary? 274
Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas 262
Characterization and Gene Expression Analysis of Serum-Derived Extracellular Vesicles in Primary Aldosteronism 262
Assessment of a non-physician screening program for hypertension and cardiovascular risk in community pharmacies 251
Current assessment of pulse wave velocity: comprehensive review of validation studies 249
Coaches’ Subjective Perceptions and Physical Performance: Key Factors in Youth Football Talent Identification—An Exploratory Study 247
Effect of Adrenocorticotropic Hormone Stimulation During Adrenal Vein Sampling in Primary Aldosteronism 246
Assessing resting heart rate in adolescents: determinants and correlates. 241
Hypertensive emergencies and urgencies in emergency departments: a systematic review and meta-analysis 239
Reverse blood pressure dipping as marker of dysautonomia in Parkinson disease 237
18-Hydroxycorticosterone, 18-Hydroxycortisol, and 18-Oxocortisol in the Diagnosis of Primary Aldosteronism and Its Subtypes 237
Pulse wave velocity and short-term outcome in patients requiring intravascular volume expansion: A pilot study 229
Teratocarcinoma-derived growth factor-1 is upregulated in aldosterone-producing adenomas and increases aldosterone secretion and inhibits apoptosis in vitro 223
Cardiovascular organ damage and blood pressure levels predict adverse events in multiple myeloma patients undergoing carfilzomib therapy 223
Combinations of Renin-Angiotensin-Aldosterone System Antagonists: True Advantages? 219
Familial hyperaldosteronism type III 218
Impact of different diagnostic criteria during adrenal vein sampling on reproducibility of subtype diagnosis in patients with primary aldosteronism 217
[Arterial hypertension and cognitive deficit] 214
Aldosterone does not modify gene expression in human endothelial cells 213
Antihypertensive Bridge Therapy by Continuous Drug Infusion with an Elastomeric Pump in Device-Resistant Hypertension 202
Non Invasive Evaluation of Cardiac Hemodynamics in End Stage Renal Disease (ESRD). 199
Accuracy of a Symptom-Based Approach to Identify Hypertensive Emergencies in the Emergency Department 199
Arterial hypertension and multiple myeloma: Physiopathology and cardiovascular risk and ‘practical’ indications in patients receiving carfilzomib 197
Effects of Carfilzomib Therapy on Left Ventricular Function in Multiple Myeloma Patients 195
Bioequivalence study of nicardipine solution versus nicardipine tablets 186
Adrenal endothelin-1 levels are not associated with aldosterone secretion in primary aldosteronism 179
Bradykinin B2 receptor gene C-58T polymorphism and insulin resistance. A study on obese patients 172
Knowledge on arterial hypertension in general population: Results from a community pharmacy screening program 172
Arterial hypertension: a cause of cognitive impairment and of vascular dementia 170
A Non-Invasive Method for Detection of Antihypertensive Drugs in Biological Fluids: The Salivary Therapeutic Drug Monitoring 169
Is Primary Aldosteronism Still Largely Unrecognized? 168
Risk factors for arterial hypertension after liver transplantation 167
Accuracy of transthoracic echocardiography in the assessment of proximal aortic diameter in hypertensive patients: comparison with cardiac magnetic resonance 166
A structured physical activity program in an adolescent population with overweight or obesity: a prospective interventional study 164
Nicardipine: a hypotensive dihydropyridine-type calcium antagonist with a peculiar cerebrovascular profile 160
Liddle syndrome: Review of the literature and description of a new case 160
Blood pressure circadian rhythm alterations in alpha-synucleinopathies 159
A case of adrenal vein sampling in primary aldosteronism with homolateral suppression 159
Cardiovascular complications in patients with autonomic failure 158
Adherence to antihypertensive therapy and therapeutic dosage of antihypertensive drugs 157
Inaccuracy of Right Atrial Pressure Estimates Through Inferior Vena Cava Indices 155
The 2020 Italian Society of Arterial Hypertension (SIIA) practical guidelines for the management of primary aldosteronism 155
A Novel Approach to Left Ventricular Filling Pressure Assessment: The Role of Hemodynamic Forces Analysis 155
Proximal aortic diameter evolution in hypertensive patients with mild-to-moderate aortic dilatation: a 5-year follow-up experience 154
Procedural Reassessment of Radiofrequency Renal Denervation in Resistant Hypertensive Patients 153
Cardiac organ damage in patients with Parkinson's disease and reverse dipping 151
Development and internal validation of a predictive model for the estimation of pheochromocytoma recurrence risk after radical surgery 151
TRATTAMENTO PRE- E POST-OPERATORIO 150
Cardiovascular Hypertension-Mediated Organ Damage in Hypertensive Urgencies and Hypertensive Outpatients 148
Cardiac Organ Damage and Arterial Stiffness in Autonomic Failure: Comparison With Essential Hypertension 148
Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis 148
A particular phenotype in a girl with aldosterone synthase deficiency 147
Adiponectin and insulin sensitivity in primary aldosteronism. 147
Noninvasive assessment of spontaneous baroreflex sensitivity in patients with liver cirrhosis. 145
Antihypertensive drugs and the sympathetic nervous system 145
From SGAP-Model to SGAP-Score: A Simplified Predictive Tool for Post-Surgical Recurrence of Pheochromocytoma 144
Ambulatory Blood Pressure Monitoring-Derived Short-Term Blood Pressure Variability in Primary Aldosteronism 143
A simple UHPLC-PDA method with a fast dilute-and-shot sample preparation for the quantification of canrenone and its prodrug spironolactone in human urine samples 143
Plasma steroid responses to circadian-stage-specified injection of different doses of the ACTH analogue alsactide (ACTH 1-17) in healthy adult human males. 142
Comparison of nurse attended and unattended automated office blood pressure with conventional measurement techniques in clinical practice 142
Baroreflex sensitivity correlates with left ventricular morphology and diastolic function in essential hypertension. 141
Multiple myeloma patients undergoing carfilzomib: Development and validation of a risk score for cardiovascular adverse events prediction 140
Pulse rate in childhood: reference limits. 139
Assessment of a threshold value of the plasma aldosterone/plasma renin activity ratio in the screening for primary aldosteronism. 139
Aortic size index enlargement is associated with central hemodynamics in essential hypertension 138
Echocardiographic estimation of right ventricular wall tension: haemodynamic comparison and long-term follow-up 138
Totale 29.485
Salva come PNG Salva come JPEG
Categoria #
all - tutte 156.811
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 156.811
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021457 0 0 0 0 0 0 0 0 0 0 0 457
2021/20224.056 242 315 216 272 265 233 269 226 202 245 699 872
2022/20235.159 580 386 169 498 415 1.172 428 316 544 172 269 210
2023/20243.136 381 427 204 214 196 377 191 204 90 170 281 401
2024/20257.783 158 415 346 631 1.549 678 290 577 856 610 616 1.057
2025/202614.667 1.386 873 1.106 1.991 1.687 1.007 2.307 876 1.309 1.192 745 188
Totale 51.256